Patricia McGill is among the oldest people in the U.S. with sickle cell disease, and she attributes her longevity to optimism ...

U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where ...

Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns. Pfizer ( PFE) ...

Pfizer is pulling its sickle cell disease (SCD) treatment voxelotor (Oxbryta) from global markets after data review showed an ...

One such critical issue is India’s persistent blood shortage to meet the various needs of individuals, particularly in areas ...

A man and woman, both with sickle cell, share what their experience was like finding love, and what prospective partners need ...

Sickle cell disease is a painful, inherited condition that primarily impacts African Americans. Dr. Sharl Azar, medical ...

Sickle cell disease (SCD) is a group of painful and life-threatening genetic disorders that affect hemoglobin, the major ...

The EU's drug watchdog Thursday called for the suspension of approval for Pfizer's medicine to treat sickle cell disease, ...

About 100,000 Americans, mostly Black, have sickle cell disease, shortening lifespans, delaying puberty, damaging spleens and ...

On Friday, Sept. 27, lawmakers reintroduced the Sickle Cell Disease Treatment Centers Act. If passed, this bicameral bill ...

Pfizer will voluntarily pull its sickle cell disease (SCD) drug Oxbryta from all markets worldwide, a major blow to a $5.4 ...